J. Goldman & Co’s Amylyx Pharmaceuticals AMLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.66M | Buy |
+258,600
| New | +$1.66M | 0.04% | 216 |
|
|
2024
Q2 | – | Hold |
0
| – | – | – | 306 |
|
|
2024
Q1 | – | Sell |
-19,029
| Closed | -$280K | – | 274 |
|
|
2023
Q4 | $280K | Sell |
19,029
-165,878
| -90% | -$2.44M | 0.01% | 184 |
|
|
2023
Q3 | $3.39M | Buy |
184,907
+85,567
| +86% | +$1.57M | 0.12% | 108 |
|
|
2023
Q2 | $2.14M | Buy |
99,340
+31,062
| +45% | +$670K | 0.08% | 130 |
|
|
2023
Q1 | $2M | Buy |
68,278
+22,636
| +50% | +$664K | 0.08% | 145 |
|
|
2022
Q4 | $1.69M | Buy |
+45,642
| New | +$1.69M | 0.08% | 147 |
|